Case: Dietary Supplement Use Leads to Thyroid Disease

The patient claimed that the supplement was used to promote increased energy and weight loss
The patient claimed that the supplement was used to promote increased energy and weight loss

This article is written live from the American Association of Clinical Endocrinologists (AACE) 2017 Annual Meeting in Austin, TX. MPR will be reporting news on the latest findings from leading experts in endocrinology. Check back for more news from AACE 2017.


At the AACE 2017 Annual Meeting, Sarah Fishman, MD, PhD, of Lenox Hill Hospital, in New York, NY, presented a case of a patient who developed thyroid disease when taking an unregulated dietary supplement containing excessive iodine.

The case involves a 39-year old male patient who stated that he had an intentional 10-pound weight loss over a 2-month period after starting a dietary supplement that was a “fad” at his office. He claimed that this supplement was used to “promote increased energy and weight loss,” however, he could not recall the name of the supplement at the time of presentation.

The patient's physical exam was unremarkable and he was negative for exophthalmos, thyromegaly, thyroid nodules, tremor, and hyperreflexia. Laboratory analysis found a suppressed TSH level (<0.03 IU/mL), an increased FT4 level (2.88ng/dL), and an increased TT3 level (470ng/dL). Additionally, the patient was negative for TSH receptor and thyroglobulin antibodies, but had a positive thyroperoxidase antibody titer (56 IU/mL).

The study authors noted that thyroid US revealed "multiple nodules, a left-sided sub-centimeter nodule, and two nodules in the right lobe, the largest of which was 1.3cm hypoechoic, with internal vascularity." A biopsy was conducted and the nodule was found to be benign. 

After investigation, the supplement was identified as “Survival Shield X2,” which the patient discontinued. The authors noted that, after 2 months, the patient's thyroid function tests were within normal limits and thyroperoxidase antibody titers gradually returned to normal by 8 months.

The authors stated that this particular unregulated supplement contains 1950mcg of potassium iodide in one daily serving, which greatly exceeds the recommended daily value of iodine (150mcg). “Many supplements exempt from FDA approval contain iodine and may have unknown risks to consumers,” Dr. Fishman stated.

Dietary supplements have been increasing in popularity and are often promoted as weight loss aids or energy boosters. In addition, some claim to promote increased thyroid health; these supplements often contain iodine at amounts higher than the recommended daily allowance.  In addition to the development of both hypo-and hyperthyroidism, iodine excess has been associated with autoimmune thyroid disease.

For continuous endocrine news coverage from the AACE 2017 Annual Meeting, check back to MPR's AACE page for the latest updates.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs